Platelet Aggregation Inhibitors [Pharmacological Action]

Tree Number(s): D010975

MeSH Unique ID: D010975

• helenalin (Supplementary Concept)
• linsidomine (Supplementary Concept)
• canadine (Supplementary Concept)
• magnolol (Supplementary Concept)
• 3,4-dihydroxyphenylethanol (Supplementary Concept)
• 1,2-dipalmitoyl-3-phosphatidylethanolamine (Supplementary Concept)
• protopine (Supplementary Concept)
• trilinolein (Supplementary Concept)
• 6-methyl-2-ethyl-3-hydroxypyridine (Supplementary Concept)
• acetylsalicylic acid lysinate (Supplementary Concept)
• essential 303 forte (Supplementary Concept)
• picotamide (Supplementary Concept)
• tranilast (Supplementary Concept)
• 1,2-benzisothiazoline-3-one (Supplementary Concept)
• triflusal (Supplementary Concept)
• plafibride (Supplementary Concept)
• enfenamic acid (Supplementary Concept)
• indobufen (Supplementary Concept)
• diadenosine tetraphosphate (Supplementary Concept)
• anagrelide (Supplementary Concept)
• 12-HPETE (Supplementary Concept)
• cilostamide (Supplementary Concept)
• S-nitrosocysteine (Supplementary Concept)
• glycocalicin (Supplementary Concept)
• pycnogenols (Supplementary Concept)
• thromboxane A2, carbocyclic (Supplementary Concept)
• cloricromen (Supplementary Concept)
• carboprostacyclin (Supplementary Concept)
• 3-n-butylphthalide (Supplementary Concept)
• fibrinopeptides gamma (Supplementary Concept)
• oxophenylarsine (Supplementary Concept)
• andrographolide (Supplementary Concept)
• argatroban (Supplementary Concept)
• S-nitrosomercaptoethanol (Supplementary Concept)
• 3,4-dihydroxyacetophenone (Supplementary Concept)
• 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate (Supplementary Concept)
• eicosapentaenoic acid ethyl ester (Supplementary Concept)
• Quin2 (Supplementary Concept)
• ataprost (Supplementary Concept)
• dauricine (Supplementary Concept)
• trequinsin (Supplementary Concept)
• defibrotide (Supplementary Concept)
• CV 3988 (Supplementary Concept)
• ibudilast (Supplementary Concept)
• dazmegrel (Supplementary Concept)
• piroximone (Supplementary Concept)
• sulotroban (Supplementary Concept)
• 9-O-methanoprostaglandin I (Supplementary Concept)
• 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone (Supplementary Concept)
• diallyl trisulfide (Supplementary Concept)
• tesmilifene (Supplementary Concept)
• arginyl-glycyl-aspartyl-serine (Supplementary Concept)
• UD CG 212 Cl (Supplementary Concept)
• beraprost (Supplementary Concept)
• ajoene (Supplementary Concept)
• glycyl-arginyl-glycyl-aspartyl-serine (Supplementary Concept)
• 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one (Supplementary Concept)
• alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol (Supplementary Concept)
• ONO 3708 (Supplementary Concept)
• daltroban (Supplementary Concept)
• WEB 2086 (Supplementary Concept)
• tautomycin (Supplementary Concept)
• Satigrel (Supplementary Concept)
• 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP (Supplementary Concept)
• RS 5186 (Supplementary Concept)
• S 145 (Supplementary Concept)
• clentiazem (Supplementary Concept)
• echistatin (Supplementary Concept)
• BW A868C (Supplementary Concept)
• atrinositol (Supplementary Concept)
• vapiprost (Supplementary Concept)
• ridogrel (Supplementary Concept)
• 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (Supplementary Concept)
• ST 638 (Supplementary Concept)
• FK 409 (Supplementary Concept)
• ramatroban (Supplementary Concept)
• 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole (Supplementary Concept)
• bepafant (Supplementary Concept)
• efegatran (Supplementary Concept)
• sarpogrelate (Supplementary Concept)
• naftopidil (Supplementary Concept)
• Ro 31-7549 (Supplementary Concept)
• Ro 31-8220 (Supplementary Concept)
• N-acetylsphingosine (Supplementary Concept)
• KW 3635 (Supplementary Concept)
• acetylphenylalanyl-prolyl-boroarginine (Supplementary Concept)
• BN 50730 (Supplementary Concept)
• TCV 309 (Supplementary Concept)
• emoxypine succinate (Supplementary Concept)
• triflavin (Supplementary Concept)
• Foropafant (Supplementary Concept)
• rhodostomin (Supplementary Concept)
• draflazine (Supplementary Concept)
• SR 46349B (Supplementary Concept)
• pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (Supplementary Concept)
• ifetroban (Supplementary Concept)
• IH 764-3 (Supplementary Concept)
• policosanol (Supplementary Concept)
• relcovaptan (Supplementary Concept)
• GEA 3162 (Supplementary Concept)
• lamifiban (Supplementary Concept)
• DMP 728 (Supplementary Concept)
• (2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid (Supplementary Concept)
• 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (Supplementary Concept)
• xemilofiban (Supplementary Concept)
• E 4021 (Supplementary Concept)
• sibrafiban (Supplementary Concept)
• nitroaspirin (Supplementary Concept)
• aloxistatin (Supplementary Concept)
• cangrelor (Supplementary Concept)
• clopidogrel carboxylic acid (Supplementary Concept)
• vorapaxar (Supplementary Concept)
• MP407 (Supplementary Concept)
• JLX001 (Supplementary Concept)
• S007-867 (Supplementary Concept)
• BMS-986120 (Supplementary Concept)
• Alprostadil (MeSH Term)
• Aspirin (MeSH Term)
• Dipyridamole (MeSH Term)
• Ketanserin (MeSH Term)
• Pentoxifylline (MeSH Term)
• Epoprostenol (MeSH Term)
• Ticlopidine (MeSH Term)
• Trapidil (MeSH Term)
• Iloprost (MeSH Term)
• Disintegrins (MeSH Term)
• Milrinone (MeSH Term)
• S-Nitrosothiols (MeSH Term)
• S-Nitrosoglutathione (MeSH Term)
• Aspirin, Dipyridamole Drug Combination (MeSH Term)
• Prasugrel Hydrochloride (MeSH Term)
• Clopidogrel (MeSH Term)
• Sevoflurane (MeSH Term)
• Resveratrol (MeSH Term)
• Abciximab (MeSH Term)
• Cilostazol (MeSH Term)
• Tirofiban (MeSH Term)
• Ticagrelor (MeSH Term)
• Eptifibatide (MeSH Term)

All MeSH Categories
Pharmacological Actions Category
Platelet Aggregation Inhibitors